Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

Australia's medicines regulator has issued warnings for diabetes and weight-loss drugs including Ozempic and Mounjaro, linking them to a rare but severe eye disorder that could cause blindness. The Therapeutic Goods Administration's alert comes after 36 cases of the condition were linked to these GLP-1 medications in Australia. Product information for the drugs has been updated with the warning.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton